HUT44040A - Process for production of new derivatives of pregnane - Google Patents

Process for production of new derivatives of pregnane

Info

Publication number
HUT44040A
HUT44040A HU852282A HU228285A HUT44040A HU T44040 A HUT44040 A HU T44040A HU 852282 A HU852282 A HU 852282A HU 228285 A HU228285 A HU 228285A HU T44040 A HUT44040 A HU T44040A
Authority
HU
Hungary
Prior art keywords
derivatives
pregnane
production
new derivatives
eczema
Prior art date
Application number
HU852282A
Other languages
English (en)
Inventor
Issei Nitta
Kenichiro Nakao
Motoyoshi Miyake
Akira Maruyama
Hiroaki Ueno
Junko Takashima
Original Assignee
Mitsubishi Chem Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP58164772A external-priority patent/JPS6056997A/ja
Priority claimed from JP59120439A external-priority patent/JPS611698A/ja
Application filed by Mitsubishi Chem Ind filed Critical Mitsubishi Chem Ind
Publication of HUT44040A publication Critical patent/HUT44040A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HU852282A 1983-09-07 1984-09-04 Process for production of new derivatives of pregnane HUT44040A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58164772A JPS6056997A (ja) 1983-09-07 1983-09-07 新規な６−酸素化コルチコイド／７α−カ−ボネ−ト誘導体およびその製法
JP59120439A JPS611698A (ja) 1984-06-12 1984-06-12 新規なコルチコイド誘導体およびその製法

Publications (1)

Publication Number Publication Date
HUT44040A true HUT44040A (en) 1988-01-28

Family

ID=26458022

Family Applications (2)

Application Number Title Priority Date Filing Date
HU843321A HU201092B (en) 1983-09-07 1984-09-04 Process for producing new corticosteroid derivatives and pharmaceutical compositions comprising same
HU852282A HUT44040A (en) 1983-09-07 1984-09-04 Process for production of new derivatives of pregnane

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HU843321A HU201092B (en) 1983-09-07 1984-09-04 Process for producing new corticosteroid derivatives and pharmaceutical compositions comprising same

Country Status (9)

Country Link
EP (1) EP0136586B1 (hu)
AT (1) ATE41013T1 (hu)
AU (1) AU558725B2 (hu)
DD (3) DD232497A5 (hu)
DE (1) DE3476885D1 (hu)
DK (1) DK168631B1 (hu)
HU (2) HU201092B (hu)
NO (1) NO843548L (hu)
SU (2) SU1561827A3 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4025342A1 (de) * 1990-08-10 1992-02-13 Hoechst Ag In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel
US6861415B2 (en) 1996-05-01 2005-03-01 The United States Of America As Represented By The Department Of Health And Human Services 21-substituted progesterone derivatives as new antiprogestational agents
US6900193B1 (en) 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518179B1 (de) * 1964-10-07 1970-01-02 Warner Lambert Pharmaceutical Verfahren zur Herstellung von 17alpha-Acyloxy-20-keto-21-desoxy-steroiden
US3558675A (en) * 1969-06-30 1971-01-26 Merck & Co Inc Steroid carbonates and process
GB1440063A (en) * 1972-08-11 1976-06-23 Glaxo Lab Ltd 17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids
DE2735110A1 (de) * 1977-08-04 1979-02-15 Hoechst Ag Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
DE3133082A1 (de) * 1981-08-18 1983-03-10 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue hydrocortison-derivate, ihre herstellung und verwendung

Also Published As

Publication number Publication date
HUT37944A (en) 1986-03-28
DE3476885D1 (en) 1989-04-06
SU1551250A3 (ru) 1990-03-15
HU201092B (en) 1990-09-28
DK168631B1 (da) 1994-05-09
EP0136586B1 (en) 1989-03-01
NO843548L (no) 1985-03-08
ATE41013T1 (de) 1989-03-15
DD229702A5 (de) 1985-11-13
SU1561827A3 (ru) 1990-04-30
DK407384A (da) 1985-03-08
EP0136586A3 (en) 1986-01-29
AU3231184A (en) 1985-03-14
DD232497A5 (de) 1986-01-29
EP0136586A2 (en) 1985-04-10
AU558725B2 (en) 1987-02-05
DD229135A5 (de) 1985-10-30
DK407384D0 (da) 1984-08-24

Similar Documents

Publication Publication Date Title
HK1032545A1 (en) Nitrix oxide donor composition and method for treatment of anal disorders
ES549012A0 (es) Procedimiento para la produccion de derivados diarilicos de compuestos antiinflamatorios antialergicos.
EP0624595A3 (de) nor-Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel.
ES488120A1 (es) Procedimiento para la preparacion de corticoide-17-alcohil- carbonatos
IT1237472B (it) Derivati di acido 3-indolpiruvico, loro procedimento di produzione ed impiego terapeutico.
IE780280L (en) Imidazole derivatives
AU5471190A (en) Method of topically treating acne vulgaris
CA1015552A (en) Method and manufacturing a steering knuckle and spindle
AU6857887A (en) Therapeutic agent
HUT44040A (en) Process for production of new derivatives of pregnane
ES2001578A6 (es) Procedimiento para la fabricacion continua de esterillas absorbentes para panales
AU3329984A (en) Tar and linolenic acid topical preparation
IE39738B1 (en) Novel triamcinolone derivative
IT1189298B (it) Procedimento per produrre i glicosa minoglicani dermatansolfato ed eparan-solfato sostanzialmente puri e loro impiego farmaceutico
ATA900589A (de) Stereospezifisches verfahren fuer die herstellung von enantiomeren des 3-substituierten furo (3,4-c) pyridins, so erhaltene enantiomere oder mischungen davon sowie diese enthaltene therapeutische mittel
NO870998L (no) FremgangsmŸte for fremstilling av nye, terapeutisk aktive acetamid-derivater.
IE830664L (en) Treating acne
ES8407476A1 (es) Procedimiento de preparar compuestos piridinicos.
DE3169122D1 (en) Process for the manufacture of field-effect transistors with selfaligned gate electrode, and transistors made by this process
GB8917138D0 (en) Process for the production of stable dispersions,the dispersions so produced,and the use thereof in the manufacture of polyurethanes
IE802535L (en) 1-aminopropan-2-ols
FR2558470B1 (fr) Steroides du type (16, 17-a) cyclopentanopregnenes et leurs utilisations therapeutiques, notamment en tant qu'agents anti-inflammatoires
HU179593B (en) Process for producing 9-alpha-chloro-11-beta,17-dihydroxy-pregna-1,4-diene-3,20-dione derivatives
GB1552982A (en) Process for the production of 3-hydroxy 1,2,4-triazole derivatives
FI852923L (fi) Foerfarande foer framstaellning av 1,3-dihydro-4-pyridoyl-2h-imidazol-2-oner.

Legal Events

Date Code Title Description
DFA9 Temporary protection cancelled due to abandonment